Fingerprint
Dive into the research topics where Sikander Ailawadhi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Clinical course, risk factors and mitigating strategies for Immune effector cell-associated late onset neurotoxicities after ciltacabtagene autoleucel CAR-T in multiple myeloma
Lim, K. J. C., Tan, M., Parrondo, R., Chhabra, S., Dooley, K., De Menezes Silva Corraes, A., Carabenciov, D., Gertz, M., Hwa, L., Haily, S., Kapoor, P., Kourelis, T., Warsame, R., Cook, J., Binder, M., Bergsagel, P. L., Yadav, U., Wiedmeier-Nutor, E., Geyer, S. & Ailawadhi, S. & 4 others, , Dec 2026, In: Blood cancer journal. 16, 1, 18.Research output: Contribution to journal › Article › peer-review
Open Access -
Dose Delays and Treatment Interruptions Secondary to Ocular Toxicity From BCMA-Directed Antibody Drug Conjugate Therapy in Relapsed Multiple Myeloma
Rees, M. J., Xu, T. T., Atallah-Yunes, S. A., Lim, K. J. C., Ailawadhi, S., Parrondo, R., Fonseca, R., Bergsagel, P. L., Hayman, S., Dispenzieri, A., Buadi, F., Dingli, D., Warsame, R., Kapoor, P., Abeykoon, J. P., Gertz, M. A., Muchtar, E., Kourelis, T., Gonsalves, W. & Rajkumar, S. V. & 2 others, , Feb 2026, In: Clinical Lymphoma, Myeloma and Leukemia. 26, 2, p. e233-e240.e2Research output: Contribution to journal › Article › peer-review
-
Optimizing Selection of Bridging Therapies Prior to CAR-T Therapy Administration for Multiple Myeloma: Clinical Pearls From an Expert Roundtable
Ailawadhi, S., Anderson, L. D., Dhakal, B., Shune, L., Sborov, D. W. & Hansen, D. K., Feb 2026, In: Clinical Lymphoma, Myeloma and Leukemia. 26, 2, p. 85-93 9 p.Research output: Contribution to journal › Short survey › peer-review
Open Access -
Prospective patient preference study for Bruton tyrosine kinase inhibitor (BTKi) treatment attributes and factors affecting patient shared decision-making in chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) in the United States (US)
Ailawadhi, S., Challagulla, S., Totev, T. I., Pilon, D., Meng, Y., Xue, M., Chen, Z., Wang, Y. & Yang, K., 2026, In: Expert Review of Hematology. 19, 3, p. 321-331 11 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Real-World Outcomes of Newly Diagnosed Multiple Myeloma Patients Treated With Front-Line Daratumumab Lenalidomide and Dexamethasone
Parrondo, R. D., de Menezes, R. C. B., Sledge, H., Nayyar, M., Yadav, K., Bergsagel, L., Fonseca, R., Kapoor, P., Buadi, F., Gertz, M. A., Dispenzieri, A., Roy, V., Abdallah, N., Chhabra, S., Rajkumar, S. V., Gonsalves, W. I., Cook, J., Kumar, S., Chanan-Khan, A. A. & Ailawadhi, S., Apr 2026, In: American journal of hematology. 101, 4, p. 884-888 5 p.Research output: Contribution to journal › Letter › peer-review